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INTRODUCTION
Organotypic hippocampal tissue slice culture (OHSC) is a 
unique platform used in various fields of neuroscience. In 
this ‘ex vivo’ system, hippocampal slices are cultured as a still 
integrated tissue maintaining its typical features as it would 
in the in vivo brain.1,2 Thus, in contrast to the primary neuronal 
culture where only neurons are selected and cultured, OHSC 
enables investigation of specific characteristics of in vivo brain 
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such as synaptogenesis, interregional connectivity, neurovas-
cular coupling, and neuro-glial dynamics.3-6 In addition, doz-
ens of slices are generally obtained from a single mouse brain. 
So they can serve as homogenous platforms which would be 
particularly useful for studies to compare effects of various ex-
ternal conditions (i.e., drugs) while minimizing both inter-in-
dividual variability and the sacrifice of experimental animals.
However, despite these obvious advantages, ‘conventional’ 
OHSC system has held several limitations towards broader 
usage. First, owing to the vulnerability of neurons to insuffi-
cient supply of oxygen inevitably accompanied during ex-
perimental procedures, it has been made mostly of neonatal 
brains, which may be inappropriate for studies on brain age-
ing and many age-related neuropsychiatric disorders.7-9 Sec-
ond, it has been cultured only for a limited time duration (sev-
eral days to a week), which is unsuitable for the translational 
researches since most of psychotropic drugs generally mani-
fest their proper actions in 3–4 weeks.10,11 More importantly, 
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long-term OHSC from various transgenic disease model mice 
still remains to be established. This would be obviously a chal-
lenge in that mutually exclusive two conditions should be 
achieved simultaneously; on the one hand, the specific patho-
genic properties should be well preserved for the OHSC to be 
a valid ex vivo disease model.2,11 On the other hand, despite its 
own pathogenesis, overall viability of neuronal tissue should 
be well maintained over a sufficient period. However, if well 
established, such ex vivo disease model system would be of 
value in terms of reducing expense and sacrifice of model ani-
mals in addition to the general advantages of OHSC.
Therefore, we attempted to establish OHSC from 3xTg-AD 
mouse, a model of Alzheimer’s disease (AD), and examined 
its validity as a putative ex vivo model of AD. Although cellu-
lar as well as animal models of AD have been widely used, 
little has been known about the availability of ‘tissue’ models 
of AD. So we assumed that several aspects are required for this 
tissue model system to be practically useful. First, the hippo-
campal tissue should be obtained from old mouse; old enough 
to develop obvious AD-related pathologies. Second, the tissue 
should stably remain organotypic over a period, long enough 
to provide sufficient time to examine chronic effects of drug 
administration. Third, it should maintain disease-related char-
acteristics over the period to be a valid disease-model. Fourth, 
as a prominent advantage of OHSC, not only neurons but also 
glial cells should be well preserved in the sliced tissues, which 
would be useful for the studies on neuro-glial interactions in 
the context of AD-related neuroinflammation.12
We report here that using serum-free (SF) culture media13 
is an effective approach to establish OHSC from old (12–14 
months) 3xTg-AD mice over 4 weeks. When compared to 
OHSC from young (2–4 months) 3xTg-AD or old (12–14 
months) wild type (WT) C57BL/6J mice, OHSC from the old 
3xTg-AD mice showed obvious pathological features yet com-
parable cellular structure. This approach could serve to facili-
tate the development of a new ex vivo model of other neuro-
degenerative disorders as well.
METHODS
Animals 
WT (C57BL/6J, Joongang, Seoul, Korea) and 3xTg-AD mice 
(AD mice) harboring APPSwe, tauP301L and PS1M148V 
transgenes (The Jackson Laboratory, Bar Harbor, ME, USA) 
were used in this study. There were 3 groups; young AD (2–4 
months), old AD (12–14 months) and, old WT mice (12–14 
months). All mice were female, and housed in groups of 2–4 
per cage. Food and water were provided ad libitum under 
12/12 hr light-dark cycles. All animal studies were approved by 
the Committee for the Care and Use of Laboratory Animals at 
Yonsei University Health System (YUHS-IACUC 2013-0082) 
and performed according to the National Institute of Health 
guidelines for the Care and Use of Laboratory Animals. 
Organotypic hippocampal slice culture 
OHSC was performed based on the method described by 
Stoppini et al.14 with slight modifications.13,15,16 Following de-
capitation of mice, hippocampi were rapidly dissected, refined 
and then placed into a chilled dissection medium (DM) com-
posed of hibernate A (BrainBits, Springfield, IL, USA), 2% 
B27 supplement, 2 mM L-glutamine by GlutamMax and anti-
biotic-antimycotics (all from Invitrogen, Carlsbad, CA, USA). 
Isolated hippocampi were sliced coronally at 300 µm thickness 
using a manual tissue slice chopper (#390610, Vibratome com-
pany, Saint Louis, MO, USA). The slices were gently separat-
ed from each other in fresh chilled DM and transferred onto 
membrane inserts (PICM0RG50; Millipore, Billerica, MA, 
USA) in 6-well plates containing growth medium. 4–6 slices 
were placed in one insert and incubated in a humidified 5% 
CO2 atmosphere at 37°C. The medium was entirely changed 
at day 1 and changed by half 3 times a week thereafter for 3–4 
weeks. 
To confirm effectiveness of SF medium, slices were cultured 
in two types of medium, which is serum-containing (SC) and 
SF (Table 1). SC medium consisted of Neurobasal A with 20% 
horse serum, 2 mM L-glutamine, and antibiotics-antimycot-
ics. SF medium contained Neurobasal A with 2% B27, 2 mM L-
glutamine, and antibiotic-antimycotics. After 4 days in vitro 
(DIV), antibiotic-antimycotics was removed from both media.
DAPI staining and AlamarBlue assay 
To investigate cellular distribution, slices were stained with 
4’, 6-diamidino-2-phenylindole (DAPI; 10 μg/mL, Sigma-Al-
drich Co., Saint Louis, MO, USA) for 30 min and imaged us-
Table 1. Composition of media
Serum-containing Serum-free
1–4 DIV After 4 DIV 1–4 DIV After 4 DIV
Neurobasal A with 20% horse serum
2 mM L-glutamine
Antibiotics-antimycotics
Neurobasal A with 20% 
horse serum
2 mM L-glutamine
Neurobasal A with 2% B27
2 mM L-glutamine
Antibiotics- antimycotics
Neurobasal A with 2% B27
2 mM L-glutamine
DIV: days in vitro
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ing an inverted fluorescence microscope with a camera (Olym-
pus, Central Valley, PA, USA) at 1, 4, 7, 14, 21, and 28 DIV. 
The fluorescent intensity of the slices was quantified by Im-
ageJ in the public domain (1.47v, National Institutes of Health, 
Bethesda, MD, USA) in a 4X field containing the whole hippo-
campal area. Measured intensity was corrected by background 
and selected field area. Four slices per group were measured 
for statistical analysis. 
Neuronal metabolism was analyzed by AlamarBlue cell 
health indicator assay (Invitrogen) as previously described.17,18 
At 1 DIV and 28 DIV, a 1:10 dilution of the AlamarBlue in the 
fresh culture medium was incubated with the slice cultures 
for 24 hr. After incubation, colorimetric readings were evalu-
ated with the UV spectrophotometer at 570 nm. Blank stan-
dard was AlamarBlue-mixed media incubated without slices. 
6 slices per well were used for 1 assay. 4 assays were used in 
each group for statistics. 
Quantification of β-amyloid (Aβ) by ELISA 
In each well, 5 slices were placed on the membrane and cul-
tured for 4 weeks. At 28 DIV, both the slices and culture media 
were harvested 48 hr after the last renewal of media. To mea-
sure Aβ in the tissue, slices were homogenized in RIPA lysing 
buffer containing 50 mM Tris-HCl, 0.1% SDS, 1% Triton X-100, 
150 mM NaCl, 0.5% Sodium deoxycholate, 2 mM EDTA and 
protease inhibitor for 15 minute. The homogenized samples 
were centrifuged and used for ELISA procedure. For measur-
ing Aβ in the media, we concentrated it using Amicon Ultra-0.5 
mL centrifugal filters (Millipore), because absolute quantity 
of Aβ in the media was too little to measure. Aβ was measured 
by Human Aβ (1-42) ELISA kit (EZHS42, Millipore). Aβ level 
from slices (tissue) and media (secreted) were normalized by 
protein level measured with Pierce BCA protein assay kit 
(PJ209596A, Thermo Fisher Scientific, Waltham, MA, USA) 
and compared across groups. Slices and media from 3 wells in 
each group were used for statistical analysis. 
Staining of amyloid plaque and glial cell 
For histological staining, slice cultures were washed with 
phosphate-buffered saline (PBS), and then fixed with 4% para-
formaldahyde for 30 min. After fixing, pieces of membrane 
with slices were cut individually and placed in storing buffer 
consisting of PBS with 0.3% ethylene glycol and 0.3% glycerin 
before staining. Through staining process, slices were handled 
in a floating condition. Slices were permeabilized by incubation 
in PBS with 0.3% Tx-100 for 3 hr in room temperature. 
For amyloid plaque staining, pretreated-slices were incu-
bated with 0.05% thioflavin-S (Sigma-Aldrich Co.) dissolved 
in 50% ethanol for 4 hr. Then, slices were washed twice with 
50% ethanol briefly and then washed with distilled water (DW) 
three times. 
To observe immunoreactivity for activated astrocytes, fix-
ing and permeabilization steps were proceeded as above. After 
pretreatment, slices were blocked using 5% bovine serum al-
bumin (BSA) in PBS with 0.3% Tx-100 for overnight and then 
incubated with anti-GFAP-antibody (1:100, RRID: AB_641021, 
sc-6170, Santa Cruz) in 2% BSA in PBS with 0.3% Tx-100 for 
2 days. After washing with PBS three times, slices were labeled 
with secondary antibodies targeting donkey anti-goat IgG con-
jugated to Alexaflour 488 (1:100, RRID: AB_2340430 705-546-
147, Jackson ImmunoResearch Laboratories, West Grove, 
PA, USA) for 1 day. Slices were washed three times with PBS 
again. All slices for astrocyte staining were already stained with 
DAPI during culture.
Stained slices were mounted on 1-hole slide glasses with DW 
(plaque staining) or PBS (astrocyte staining) containing Vecta-
shield-mounting solution. Stained plaques were imaged with 
a confocal laser scanning microscope (LSM700, Carl Zeiss, 
Thornwood, NY, USA) and counted by an experimenter who 
was blind to age and genotype conditions. The fluorescence in-
tensity was analyzed by Zen2011 (Carl Zeiss).
Statistical analysis
Statistical analyses were performed using SPSS 20 (IBM 
Corp., Armonk, NY, USA). Changes in DAPI intensity accord-
ing to DIV were analyzed by the repeated measures Analysis 
of Variance (RM ANOVA). If sphericity was not assumed in 
RM ANOVA, the value after Greenhouse-Geisser correction 
was accepted. To compare 2 independent groups, the 2-tailed 
t-test was used. The 1-way ANOVA followed by Bonferroni-cor-
rected post-hoc test was performed for multiple groups. Signifi-
cance level was set at p<0.05. 
RESULTS
Long-term maintenance of hippocampal structure
To verify that SF medium is effective for long-term OHSC of 
AD mice, we compared differences in retention rates of hippo-
campal principal neurons (DAPI intensity) between conven-
tional SC versus SF medium using both young AD and WT 
mice (5 months). In RM ANOVA with independent factors as 
genotype (AD vs. WT), time (DIV), and medium (SC vs. SF), 
we found a significant main effect of time (F1.9, 22.2=69.62, p< 
0.001) and medium by time interaction (F1.9, 22.2=58.89, p< 
0.001), which indicate that DAPI intensity was maintained 
only in SF but not in SC condition as DIV increased (Figure 1). 
However, there was no main effect of genotype (F1, 12=0.81, p= 
0.39) or genotype by time interaction (F1.9, 22.2=1.57, p=0.23), 
which means that SF medium was effective for cell survival 
in long term OHSC regardless of genotypes. At 21 DIV, DAPI 
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intensity of slices from both types of mice was maintained at 
about 90–100% of the initial value in SF medium (Figure 1B). 
However, the intensity significantly decreased to less than 1% 
in the SC medium (Figure 1B). In accordance with previous 
study,13 pyramidal neurons in cornus ammonis region 3 (CA3) 
already started to disappear at 4 DIV, and few granular cells 
were DAPI-positive in the dentate gyrus (DG) at 21 DIV in SC 
medium (Figure 1A). 
As we simply identified the utility of SF medium for OHSC 
from young 3xTg-AD mice (Figure 1), next we attempted to 
this method is still effective for long-term OHSC from ‘aged’ 
AD mice. To this aim, we serially examined cellular distribu-
tion of OHSC in SF medium using old AD mice compared to 
young AD and old WT mice over 4 weeks. We found that DAPI 
fluorescence intensity was maintained around 100% of the 
initial value throughout 4 weeks in all groups (Figure 2), indi-
cated by insignificant main effect of time for DAPI intensity 
across the groups (old AD, F4, 12=0.18, p=0.95; young AD, F4, 12= 
0.20, p=0.94; old WT, F4, 12=0.67, p=0.62) (Figure 2B). These 
results confirmed that use of SF medium is an effective ap-
proach for long-term OHSC from old AD mice. 
Neuronal metabolism 
To identify whether cellular metabolism as well as cell via-
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Figure 2. Effects of age and genotype on maintenance of hippocampal structure in long-term OHSC. A: Time-dependent changes on inten-
sity of DAPI-positive nuclei (blue) in cultured hippocampal slices from young AD, old WT, and old AD mouse with serum-free medium. Yel-
low arrows indicate DAPI positive regions. B: Quantification of the DAPI-positive fluorescent intensity according to DIV in the images. No 
significant difference among 3 groups. Each point, mean±SE. Scale bars, 1 mm. DAPI: 4’,6-diamidino-2-phenylindole, WT: wild type, AD: 
Alzheimer’s disease (model), DIV: days in vitro, SF: serum-free, SC: serum-containing. 
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Figure 1. Effects of culture media and genotype on maintenance of hippocampal structure in long-term OHSC. A: DAPI-positive nuclei 
(blue) according to DIV in cultured hippocampal slices of adult WT and 3xTg-AD mouse. Yellow arrows indicate DAPI positive regions. B: 
Quantification of the DAPI-positive fluorescent intensity according to media and genotype by time. Each point, mean±SE. Scale bars, 1 
mm. **p<0.01 and ***p<0.001 indicate significance when compared to SF-WT condition in Bonferroni post hoc analysis. DAPI: 4’,6-diamidi-
no-2-phenylindole, WT: wild type, AD: Alzheimer’s disease (model), DIV: days in vitro, SF: serum-free, SC: serum-containing. 
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bility is maintained in the long-term OHSC of old AD mice 
within SF medium, we performed AlamarBlue assay and 
found that metabolic activity was well maintained at 28 DIV 
compared to the basal metabolic level measured at 1 DIV 
(Figure 3) (t=-0.33, df=6, p=0.75). 
Characteristics of AD-related pathology
To be a practically useful ex vivo platform of disease-model, 
not only cellular viability but also pathologic characteristics 
should be maintained throughout the culture period. Thus, 
we investigated the level of Aβ production, deposition of am-
yloid plaques and morphology of astrocytes in the 4-week-
cultured slices from old AD mice.
Intracellular and extracelluar Aβ
We measured intracellular and secreted levels of Aβ in sliced 
tissues and media, respectively. There were statistically sig-
nificant increases in Aβ levels in both tissues and media from 
old AD (Figure 4) (1-way ANOVA effect of group: tissue, F2, 6= 
181.77, p<0.001; media, F2, 6=38.01, p<0.001). Post-hoc test 
also identified that Aβ levels in old AD condition were signifi-
cantly higher than those in other two conditions (young AD: 
tissue, p<0.001; media, p=0.001, old WT mice: tissue, p<0.001; 
media, p=0.002). These results suggest that OHSC from old 
AD mice could provide an ex vivo system which is useful to see 
changes in intracellular production and secretion of Aβ in re-
sponse to various environmental conditions including drugs 
and toxins.
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Figure 3. Neuronal metabolism in long-term OHSC from old 
3xTg-AD mice. Cellular metabolism and viability were measured 
by AlamarBlue assay in hippocampal slices from old AD mice at 1 
DIV and 28 DIV. Each bar, mean±SE. AD: Alzheimer’s disease 
(model), DIV: days in vitro. 
Figure 4. Aβ levels in tissues and culture media in long-term OHSC from old 3xTg-AD mice. Following 4-week culture, levels of Aβ42 from 
(A) lysed hippocampal slices and (B) culture media collected for 48 hr were measured by ELISA in young 3xTg-AD, old WT C57BL/6J and 
old 3xTg-AD mice. Each bar, mean±SE. **p<0.01, ***p<0.001 by Bonferroni post-hoc analysis. Aβ: β-amyloid, AD: Alzheimer’s disease 
(model), WT: wild type. 
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Amyloid plaque
Given that another key neuropathologic feature associated 
with AD is an accumulation of amyloid plaques in the brain,19 
we attempted to visualize plaques in OHSC with thioflavin-S 
staining.20 We found that plaques were almost exclusively ob-
served only in the slices from old AD mice (Figure 5A) com-
pared to young AD (p=0.001) or old WT mice (p=0.001) (Fig-
ure 5). Most plaques in old AD mice were deposited around 
cornus ammonis region 1 (CA1) (Figure 5A), which was con-
sistent with previous studies showing that Aβ accumulation 
starts from CA1 and spreads to other regions in the hippo-
campus.21
Glial cells
Different from primary neuronal cultures, OHSC could pre-
serve structure of glial cells within sliced tissues. Because both 
quantitative and qualitative expansion of glial cells are another 
critical features of AD brain,22 we imaged astrocytes with anti-
glial fibrillary acidic protein (GFAP) antibody. One-way ANO-
VA showed that GFAP signal intensity were significantly dif-
ferent between groups in all hippocampal subregions (Figure 
6) (CA1, F2, 14=9.44, p=0.003; CA3, F2, 13=4.41, p=0.03; DG, 
F2, 12=8.34, p=0.005). Post-hoc analysis revealed that signal in-
tensity of old AD mice was significantly higher than that of 
young AD (CA1, p=0.007; DG, p=0.01) and old WT mice (CA1, 
p=0.009; DG, p=0.01) in CA1 and DG (Figure 6B and D). In 
CA3, old AD mice showed higher signal than young AD did 
(p=0.04) but not than old WT mice (p=0.16) (Figure 6C). 
Moreover, in old AD mice we observed morphologic features 
of activated astrocytes, such as hypertrophic processes and 
swollen soma, which were not the case in young AD or old WT 
mice (Figure 7).
DISCUSSION 
In this study, we examined the potential of long-term OHSC 
from old 3xTg-AD mouse to be used as an ex-vivo platform 
for translational research of AD. Consistent with our previ-
ous study,13 SF medium was found to be effective to maintain 
hippocampal structure and cellular distribution over 4 weeks, 
even with the sliced tissues from the disease model mouse 
which was old enough (12–14 months old) to develop AD-re-
lated pathologies. Not only the structure and metabolic activ-
ity of neurons, but also various pathological features, such as 
production of Aβ, deposition of amyloid plaque, and glial cell 
activation, were all well identified in the long-term cultured 
hippocampal slices from the old AD mouse.
We confirmed that OHSC from old AD mice still have ca-
pacity to generate and secrete Aβ, suggesting that this system 
is readily used to screen candidate drugs by examining if they 
suppress production or enhance clearance of Aβ or both. We 
also found that glial cell morphology in the OHSC is well main-
tained as an active form, which suggests that this system may 
be suitable for the study of neuroinflammation in the context 
of AD pathogenesis. In addition, we can obtain decades of slices 
from a single AD mouse. This would be of great help to reduce 
the expense and sacrifice of the model mice. However, one of 
the most important advantages of using many sliced tissues 
from one single mouse might be that we can manipulate a num-
ber of experimental conditions (such as drugs, toxins, or their 
doses) between virtually identical platforms. This would min-
imize the statistical noise resulting from inter-individual vari-
ability, to which in vivo studies are often liable, particularly 
when the number of animals used is not sufficient.
Additionally, our model of OHSC with 3xTg-AD mouse 
Figure 5. Amyloid plaques in long-term OHSC from old 3xTg-AD mouse. A: Amyloid plaques (bright green), stained with thioflavin-S, were 
exclusively shown in the 4-week-cultured hippocampal slices from old 3xTg-AD mouse. Photos were taken in the CA1. B: The number of 
amyloid plaques were counted bya blind experimenter in the whole hippocampus. Each bar, mean±SE. Scale bars, 100 μm. **p<0.01 by 
Bonferroni post hoc analysis. AD: Alzheimer’s disease (model), WT: wild type, CA: cornus ammonis, DG: dentate gyrus. 
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Figure 6. Activated astrocytes in long-term OHSC from old 3xTg-AD mouse. A: Representative confocal images show astrocytes stained 
with anti-GFAP-antibody (green) and DAPI-stained nuclei (blue) in the 4-week-cultured hippocampal slices from young 3xTg-AD, old WT 
C57BL/6J and old 3xTg-AD mice. GFAP signal intensity was quantitatively measured in (B) CA1, (C) CA3, and (D) DG regions. Each point, 
mean±SE. Scale bars, 100 μm. *p<0.05, **p<0.01 by Bonferroni post hoc analysis. AD: Alzheimer’s disease (model), GFAP: glial fibrillary 
acidic protein, DAPI: 4’,6-diamidino-2-phenylindole, WT: wild type, CA: cornus ammonis, DG: dentate gyrus. 
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made a step forward from OHSC using other kinds of AD mod-
els, which has recently been proposed,23,24 in terms of animal 
age and duration of culture. First, our study used 12–14 month-
old AD mice for the first time. We believe that this is of trans-
lational importance. At the age of 12–14 months, 3xTg-AD 
mice begin to generate amyloid plaques.21 We may also be able 
to apply the same method to younger 3xTg-AD mice within 
any range of age before plaque formation to investigate any 
preventive measure at earlier stage of AD pathogenesis (e.g., 
mild cognitive impairment) as well as mechanisms underly-
ing plaque formation. Second, we established OHSC over 4 
weeks, which may be a minimum period enabling studies to 
reveal genuine actions of psychotropic drugs. 
Several limitations of our study remain to be explored in the 
future. First, we did not identify the molecular basis underly-
ing the effectiveness of serum-withdrawal method on long-term 
survival of neurons in OHSC. Second, we only observed mor-
phology of activated glial cells, but not neuro-glial dynamics 
directly, which would provide some clues for contributions of 
inflammation to AD pathogenesis. Third, we did not explore 
the morphology or function of specific circuit for AD pathol-
ogy, such as cholinergic or dopaminergic neurons.2,24 Finally, 
we omitted to examine tau-related pathology in OHSC from 
AD mice. In our 3xTg-AD mice, tau pathology as well as Aβ 
deposition occurs around 8–12 months of age. So we believe 
that OHSC from 3xTg-AD mice could also be a good platform 
to study tau-related AD pathogenesis such as hyperphosphor-
ylation of tau or neurofibrillary tangle formation. We intend-
ed to only focus on Aβ pathologies for there are many different 
kinds of tau-phosphorylation sites, which would be a valuable 
subject of a separate study using this OHSC.
In conclusion, our study demonstrated that long-term OHSC 
Young
AD
Old WT
Old AD
Figure 7. Morphology of activated astrocyte in long-term OHSC from old 3xTg-AD mice. Morphological difference of astrocytes according 
to age and genotype. In the hippocampal slices from old 3xTg-AD mice, morphologic characteristics of activated astrocytes, such as hyper-
trophic process or swollen soma, were observed. Scale bars, 20 μm. WT: wild type, AD: Alzheimer’s disease (model).
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could be successfully settled from old 3xTg-AD mouse using 
SF medium, as a promising ex vivo system for AD research. 
As well as cellular distribution, pathologic characteristics of AD, 
such as Aβ overproduction, amyloid plaque formation, and 
glial cell activation, were well preserved in the ex vivo hippo-
campal tissues throughout 4 weeks of culture. This system 
could serve as a translational platform for drug candidate 
screening or in-depth study of AD pathogenesis while truly 
conforming to one of the 3R principles, the reduction of animal 
sacrifice.25
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